Roche reiterated its full-year guidance and said it is prepared to launch its giredestrant breast-cancer pill later this year.

Log in or sign up to comment.

No comments yet.

← Back to stories

Create FREE account

or login to continue

Signup with GoogleSignup with GitHubSignup with BlueskySignup with Blacksky
Sign up with email

Already have an account? Log in